{"date":"2026-01-08","count":12,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7724-2026-01-08-2201-138ibg4","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-01-08","time":"22:01:46","subject":"針對前經營團隊總經理暨董事沈家平及副總經理鄭詩靜提起刑事附帶民事訴訟","clause":"第2款","fact_date":"2025-07-16","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-01-08 22:01，「針對前經營團隊總經理暨董事沈家平及副總經理鄭詩靜提起刑事附帶民事訴訟」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-01-08-1738-1led9jx","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-01-08","time":"17:38:36","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-01-08 17:38，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-01-08-1737-9o45wp","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-01-08","time":"17:37:17","subject":"代重要子公司大江生醫生物技術(上海)有限公司公告資金貸與予TCI Biotech USA LLC一案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-01-08 17:37，「代重要子公司大江生醫生物技術(上海)有限公司公告資金貸與予TCI Biotech USA LLC一案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-01-08-1711-a3btkh","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-01-08","time":"17:11:28","subject":"公告本公司決議向金融監督管理委員會申請調整114年第1次現金增資發行價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-01-08 17:11，「公告本公司決議向金融監督管理委員會申請調整114年第1次現金增資發行價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-01-08-1700-77cynu","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-01-08","time":"17:00:11","subject":"公告本公司簽訂竹北廠資訊與通訊技術(ICT)及智慧建築(IBMS)系統等工程興建契約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-01-08 17:00，「公告本公司簽訂竹北廠資訊與通訊技術(ICT)及智慧建築(IBMS)系統等工程興建契約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-01-08-1648-suxjb2","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-01-08","time":"16:48:25","subject":"公告本公司115年第一次股東臨時會決議解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-01-08 16:48，「公告本公司115年第一次股東臨時會決議解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-01-08-1647-145rws8","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-01-08","time":"16:47:55","subject":"公告本公司115年度第一次股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-01-08 16:47，「公告本公司115年度第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-01-08-1624-jb55yw","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-01-08","time":"16:24:01","subject":"公告本公司董事會通過重要決議事項","clause":"第53款","fact_date":"2026-01-08","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-01-08 16:24，「公告本公司董事會通過重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-01-08-1606-8ib1hj","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-01-08","time":"16:06:53","subject":"本公司114年現金增資收足股款暨增資基準日公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-01-08 16:06，「本公司114年現金增資收足股款暨增資基準日公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-01-08-1551-1s99hen","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-01-08","time":"15:51:06","subject":"代重要子公司久和醫療儀器(股)公司公告與台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院簽訂銷售質子治療系統合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-01-08 15:51，「代重要子公司久和醫療儀器(股)公司公告與台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院簽訂銷售質子治療系統合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-01-08-1452-cot9y3","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-01-08","time":"14:52:18","subject":"本公司受邀參加Morgan Stanley舉辦之「Non-Deal Roadshow」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-01-08 14:52，「本公司受邀參加Morgan Stanley舉辦之「Non-Deal Roadshow」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-01-08-0635-dcasak","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-01-08","time":"06:35:49","subject":"公告本公司向美國FDA提出OBI-858新型肉毒桿菌素醫美二期人體臨床試驗申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-01-08 06:35，「公告本公司向美國FDA提出OBI-858新型肉毒桿菌素醫美二期人體臨床試驗申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}